Abnormal proteolysis is often observed during disease progression.
We, therefore, have used this model to define temporal changes in peptidomic profiles during disease progression.
Tropical countries suffer proportionally greater losses during disease outbreaks (Robar et al. 2010).
Vascular smooth muscle cells (SMC) play an essential role in remodeling the vasculature during disease progression.
The aim of this study was to investigate whether such changes occur during disease progression.
Surprisingly, in mice, soluble huntingtin levels decrease during disease progression, inversely correlating with brain aggregate load.
SNS immune interaction may enhance immune readiness during disease- or injury-induced 'fight' responses.
There are three stages during disease progression, i.e., a normal state, a pre-disease state and a disease state.
It is clear that the lipidome of lipoproteins is altered during disease development, similar to other metabolomic parameters [75].
Thus, these data implicate that Opa proteins play an important role during disease progression.
In addition, frequently, only part of the pathway is altered during disease.
